Article Information
History
- November 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Marcos J. Ramos-Benitez1,6,8,10,*,
- Jeffrey R. Strich1,2,*,
- Sara Alehashemi7,*,
- Sydney Stein1,6,
- Andre Rastegar7,
- Adriana Almeida de Jesus7,
- Farzana Bhuyan7,
- Sabrina Ramelli1,
- Ashley Babyak1,6,
- Luis Perez-Valencia1,6,
- Kevin M. Vannella1,6,
- Gabrielle Grubbs3,
- Surender Khurana3,
- Robin Gross4,
- Kyra Hadley4,
- Janie Liang4,
- Steven Mazur4,
- Elena Postnikova4,
- Seth Warner1,
- Michael R. Holbrook4,
- Lindsay M. Busch1,
- Blake Warner9,
- Willard Applefeld1,
- Sarah Warner2,
- Sameer S Kadri1,
- Richard T Davey5,
- Raphaela Goldbach-Mansky7 and
- Daniel S. Chertow1,2,6,†
- 1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD
- 2The United States Public Health Service Commissioned Corps, Rockville, MD, USA
- 3Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD
- 4Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD
- 5Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
- 6Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
- 7Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy, and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA
- 8Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, Bethesda, MD 20892
- 9Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
- 10Ponce Health Science University and Ponce Research Institute, Department of Basic Sciences, School of Medicine, Ponce, Puerto Rico, USA
- ↵†Correspondence:
Corresponding author: Daniel S. Chertow (chertowd{at}cc.nih.gov)
↵* These authors contributed equally
Posted November 13, 2022.
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
